These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 29982572

  • 1. Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
    Adam HJ, Golden AR, Karlowsky JA, Baxter MR, Nichol KA, Martin I, Demczuk W, Mulvey MR, Gilmour MW, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    J Antimicrob Chemother; 2018 Jul 01; 73(suppl_7):vii12-vii19. PubMed ID: 29982572
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    Golden AR, Adam HJ, Karlowsky JA, Baxter M, Nichol KA, Martin I, Demczuk W, Van Caeseele P, Gubbay JB, Lefebvre B, Levett PN, Zahariadis G, Haldane D, Gad R, German G, Gilmour MW, Mulvey MR, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    J Antimicrob Chemother; 2018 Jul 01; 73(suppl_7):vii20-vii31. PubMed ID: 29982573
    [Abstract] [Full Text] [Related]

  • 3. Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-2020.
    Adam HJ, Karlowsky JA, Baxter MR, Schellenberg J, Golden AR, Martin I, Demczuk W, Mulvey MR, Zhanel GG.
    J Antimicrob Chemother; 2023 May 03; 78(Suppl 1):i17-i25. PubMed ID: 37130586
    [Abstract] [Full Text] [Related]

  • 4. Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.
    Golden AR, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Vaccine; 2016 May 17; 34(23):2527-30. PubMed ID: 27085174
    [Abstract] [Full Text] [Related]

  • 5. Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.
    Golden AR, Adam HJ, Gilmour MW, Baxter MR, Martin I, Nichol KA, Demczuk WH, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2015 Jul 17; 70(7):1960-4. PubMed ID: 25761605
    [Abstract] [Full Text] [Related]

  • 6. Baseline epidemiology of Streptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccine.
    Adam HJ, Karlowsky JA, Nichol KA, Gilmour MW, Hoban DJ, Embree J, Zhanel GG.
    Microb Drug Resist; 2012 Apr 17; 18(2):176-82. PubMed ID: 22204595
    [Abstract] [Full Text] [Related]

  • 7. Comparison of PCV-10 and PCV-13 vaccine coverage for invasive pneumococcal isolates obtained across Canadian geographic regions, SAVE 2011 to 2017.
    Hink RK, Adam HJ, Golden AR, Baxter M, Martin I, Nichol KA, Demczuk W, Mulvey MR, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2021 Mar 17; 99(3):115282. PubMed ID: 33341491
    [Abstract] [Full Text] [Related]

  • 8. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Noguchi T, Yamamoto M, Matsumura Y, Nagao M, Takakura S, Ohnishi M, Ihara T, Ichiyama S.
    Vaccine; 2016 Jan 02; 34(1):67-76. PubMed ID: 26602268
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
    Karlowsky JA, Adam HJ, Golden AR, Baxter MR, Nichol KA, Martin I, Demczuk W, Mulvey MR, Gilmour MW, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    J Antimicrob Chemother; 2018 Jul 01; 73(suppl_7):vii5-vii11. PubMed ID: 29982570
    [Abstract] [Full Text] [Related]

  • 10. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan.
    Kawaguchiya M, Urushibara N, Aung MS, Ito M, Takahashi A, Habadera S, Kobayashi N.
    J Infect Public Health; 2020 Aug 01; 13(8):1094-1100. PubMed ID: 32446777
    [Abstract] [Full Text] [Related]

  • 11. Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018.
    Golden AR, Fear T, Baxter M, Adam HJ, Martin I, Demczuk W, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Diagn Microbiol Infect Dis; 2021 Oct 01; 101(2):115447. PubMed ID: 34192638
    [Abstract] [Full Text] [Related]

  • 12. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.
    Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV.
    Antimicrob Agents Chemother; 2014 Nov 01; 58(11):6484-9. PubMed ID: 25136018
    [Abstract] [Full Text] [Related]

  • 13. Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16.
    Golden AR, Baxter MR, Davidson RJ, Martin I, Demczuk W, Mulvey MR, Karlowsky JA, Hoban DJ, Zhanel GG, Adam HJ, Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD.
    J Antimicrob Chemother; 2019 Aug 01; 74(Suppl 4):iv39-iv47. PubMed ID: 31505644
    [Abstract] [Full Text] [Related]

  • 14. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ, Klugman KP, Pichichero M.
    Pediatr Infect Dis J; 2007 Feb 01; 26(2):123-8. PubMed ID: 17259873
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of serotype and multidrug-resistance of Streptococcus pneumoniae respiratory tract isolates in 265 adults and 36 children in Korea, 2002-2005.
    Lee S, Lee K, Kang Y, Bae S.
    Microb Drug Resist; 2010 Jun 01; 16(2):135-42. PubMed ID: 20370508
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility profiles and correlation with pneumococcal serotypes soon after implementation of the 10-valent pneumococcal conjugate vaccine in Brazil.
    Mott M, Caierão J, Rosa da Cunha G, Rodrigues Perez LR, Matusiak R, Pilger de Oliveira KR, d'Azevedo PA, Dias C.
    Int J Infect Dis; 2014 Mar 01; 20():47-51. PubMed ID: 24389158
    [Abstract] [Full Text] [Related]

  • 17. Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.
    Lee JK, Yun KW, Choi EH, Kim SJ, Lee SY, Lee HJ.
    J Korean Med Sci; 2017 Sep 01; 32(9):1431-1439. PubMed ID: 28776337
    [Abstract] [Full Text] [Related]

  • 18. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
    Singh J, Sundaresan S, Manoharan A, Shet A.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4501-4509. PubMed ID: 28711387
    [Abstract] [Full Text] [Related]

  • 19. Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States.
    Olarte L, Kaplan SL, Barson WJ, Romero JR, Lin PL, Tan TQ, Hoffman JA, Bradley JS, Givner LB, Mason EO, Hultén KG.
    J Clin Microbiol; 2017 Mar 16; 55(3):724-734. PubMed ID: 27847379
    [Abstract] [Full Text] [Related]

  • 20. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV.
    Clin Infect Dis; 2009 Feb 01; 48(3):e23-33. PubMed ID: 19115971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.